ResMed

Youtube Subscribe

Open: 179.65 Close: 179.17 Change: -0.48

You don't have time to read all about ResMed. An AI summarizes all the information for you.

The game is changing. There is a new strategy to evaluate ResMed fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ResMed are: ResMed, RMD, earnings, stock, CPAP, ResMeds, device, and the …

Concept Map

Semantic Network

Stock Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications. The company also provides AirView, a cloud--based system that enables remote monitoring and changing of patients' device settings..

Today's Summary

ResMed Inc. stock rises friday, still underperforms market - marketwatch.com. CEO Mick Farrell touted ongoing hardware and software growth. ResMed CEO: Weight-Loss Drugs Arent cutting Demand for Sleep Apnea Treatment. ResMeds is expected to release its next earnings report on April 25, 2024.

Today's News

ResMed Inc. stock rises friday, still underperforms market - marketwatch.com. Resmed inc. stock rose friday. ResMed CEO Mick Farrell touted ongoing hardware and software growth. ResMed AirSense™ 11 CPAP machine is a top-of-the-line auto-adjusting CPAP device designed to provide optimal comfort and ease of use for people with Sleep Apnea. The device includes access to ResMed myAir™, an online support program. ResMed Inc. (RMD) NYSE: RMD · IEX Real-Time Price · USD Add to Watchlist 179.17 -3.35 (-1.35%) February 13, 2024, 4:00 PM EST - Market closed Overview Financials Statistics Forecast Dividends Profile Chart. ResMed CPAP machines are not subject to a recall. ResMeds Personal Therapy Assistant, offered through myAir, provides interactive, voice-guided instructions and videos to help with setup. ResMed CEO: Weight-Loss Drugs Arent Cutting Demand for Sleep Apnea Treatment -- Barrons.com 1 Report Moomoo AI 01/16 02:50 ResMeds high ROCE and ability to reinvest capital at profitable rates suggest potential multi-bagger status. ResMed has reduced its global workforce by 5%, or about 500 people, to “accelerate profitable growth and power long-term success,” says CEO Mick Farrell. ResMed AirSense 11 is a smart auto-adjusting CPAP machine. ResMed Inc. markets closed S&P Futures 4,970.75 -0.50 (-0.01%) Dow Futures 38,306.00 -27.00 (0.07%) Nasdaq Futures 17,677.75 +1.00 (+0.16%) Crude Oil 77.58 - 0.29 (-0.37%) Gold 2,00260 : Will take stocks bark ToshFlagoser hisUsage RSSEdwardangelo Benny mans cannt ResMed launches AirCurve 11 series devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive positive airways pressure (EPAP) ResMeds move to enhance device capabilities through software updates aligns with expectation of continuous improvement valued by consumers and investors alike. Wall Mount ResMed AirSense 11 CPAP Custom Shelf Bestselling! Holds secure at home, in your RV, or on your boat! ResMed (RMD) stock price, quote & news - stock analysis. ResMed is in the Health Care sector and Health Care Equipment & Supplies industry. Q3 earnings are confirmed for Thursday, April 25, 2024. ResMed (NYSE: RMD) announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday. The U.S. Food and Drug Administration (FDA) on Thursday classified the recall of certain respiratory masks made by ResMed as most serious. ResMed (NYSE: RMD) is a leading healthcare company specializing in sleep apnea and chronic disease treatments. ResMed trades on the New York Stock Exchange under the ticker symbol RMD. Investors and analysts closely monitor ResMeds financial performance. ResMed has a strong track record of meeting or exceeding earnings estimates. Analysts are projecting positive growth for ResMed earnings in the upcoming quarter. ResMed is well-positioned to deliver solid financial performance. ResMeds is expected to release its next earnings report on April 25, 2024. The estimated date for ResMed earnings report is April 25. ResMed has a strong track record of beating earnings estimates.

Stock Profile

"ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California."

Keywords

Are looking for the most relevant information about ResMed? Investor spend a lot of time searching for information to make investment decisions in ResMed. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ResMed are: ResMed, RMD, earnings, stock, CPAP, ResMeds, device, and the most common words in the summary are: resmed, cpap, mask, resmeds, stock, device, airsense, . One of the sentences in the summary was: ResMeds is expected to release its next earnings report on April 25, 2024.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #resmed #cpap #mask #resmeds #stock #device #airsense.

Read more →

Youtube Subscribe

---